Financials Haleon plc

Equities

Real-time Estimate Cboe Europe Other stock markets 16:05:55 13/09/2024 BST			5-day change	1st Jan Change
392.50 ^GBX	+1.32%		+0.77%	+22.09%

10:08am	Deutsche Bank cuts AstraZeneca to 'sell'	AN
09-12	Haleon Prices Offer of EUR750 Million, GBP300 Million Notes	MT

Fiscal Period: December	2022	2023	2024	2025	2026
Net sales ¹	10,858	11,302	11,389	11,744	12,256
Change	-	4.09%	0.77%	3.12%	4.36%
EBITDA ¹	2,730	2,831	2,874	2,998	3,162
Change	-	3.7%	1.53%	4.3%	5.49%
EBIT ¹	1,825	2,549	2,561	2,673	2,824
Change	-	39.67%	0.46%	4.38%	5.66%
Interest Paid ¹	-207	-368	-322.1	-269.6	-235.5
Earnings before Tax (EBT) ¹	1,618	1,628	1,992	2,331	2,548
Change	-	0.62%	22.37%	17.02%	9.32%
Net income ¹	1,060	1,049	1,475	1,706	1,863
Change	-	-1.04%	40.65%	15.63%	9.2%
Announcement Date	02/03/23	29/02/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2022 Q1	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales ¹	2,627	2,892	2,778	2,986	2,752	2,798	2,766	2,919	2,775	2,895	4,254
Change	-	10.09%	-3.94%	7.49%	-7.84%	1.67%	-1.14%	5.53%	-4.93%	4.32%	46.96%
EBITDA	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-	569	356	627	644	689	589	655	586	741.5	985.2
Change	-	-	-37.43%	76.12%	2.71%	6.99%	-14.51%	11.21%	-10.53%	26.53%	32.88%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-	-	-	-	-	172	-	406	544	311
Change	-	-	-	-	-	-	-	-100%	-	33.99%	-42.83%
Net income ¹	343	-	-	-	298	365	-3	423	303	398.4	561.8
Change	-	-100%	-	-	-	22.48%	-	-	-28.37%	31.5%	41.01%
Announcement Date	01/06/22	10/11/22	02/03/23	03/05/23	02/08/23	02/11/23	29/02/24	01/05/24	01/08/24	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2022 S1	2022 S2	2023 S1	2023 S2	2024 S1	2024 S2
Net sales ¹	5,188	5,670	5,738	5,564	5,694	5,698
Change	-	9.29%	1.2%	-3.03%	2.34%	0.08%
EBITDA ¹	-	-	1,406	1,425	1,442	1,449
Change	-	-	-	1.35%	1.19%	0.49%
EBIT ¹	-	-	1,271	1,278	1,293	1,314
Change	-	-	-	0.55%	1.17%	1.62%
Charge d'intérêts ¹	-	-	-181	-187	-162	-158
Earnings before Tax (EBT)	-	-	-	-	-	-
Change	-	-	-	-	-	-
Net income	-	-	-	-	-	-
Change	-	-	-	-	-	-
Announcement Date	29/09/22	02/03/23	02/08/23	29/02/24	01/08/24	-

¹GBP in Million

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026
Net Debt ¹	9,868	8,514	7,442	6,714	6,036
Change	-	-13.72%	-12.59%	-9.78%	-10.1%
Announcement Date	02/03/23	29/02/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026
CAPEX ¹	304	234	330.5	341.2	359.1
Change	-	-23.03%	41.24%	3.25%	5.22%
Free Cash Flow (FCF) ¹	1,759	1,866	1,436	1,712	1,824
Change	-	6.08%	-23.02%	19.19%	6.55%
Announcement Date	02/03/23	29/02/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	25.14%	25.05%	25.24%	25.52%	25.8%
EBIT Margin (%)	16.81%	22.55%	22.48%	22.76%	23.04%
EBT Margin (%)	14.9%	14.4%	17.49%	19.85%	20.79%
Net margin (%)	9.76%	9.28%	12.95%	14.53%	15.2%
FCF margin (%)	16.2%	16.51%	12.61%	14.58%	14.88%
FCF / Net Income (%)	165.94%	177.88%	97.36%	100.36%	97.92%
Profitability
ROA	3.06%	3.05%	4.55%	4.98%	5.25%
ROE	4.97%	6.37%	9.88%	9.8%	10.05%
Financial Health
Leverage (Debt/EBITDA)	3.61x	3.01x	2.59x	2.24x	1.91x
Debt / Free cash flow	5.61x	4.56x	5.18x	3.92x	3.31x
Capital Intensity
CAPEX / Current Assets (%)	2.8%	2.07%	2.9%	2.91%	2.93%
CAPEX / EBITDA (%)	11.14%	8.27%	11.5%	11.38%	11.36%
CAPEX / FCF (%)	17.28%	12.54%	23.01%	19.93%	19.68%
Items per share
Cash flow per share ¹	0.2233	0.2267	0.1967	0.2181	0.2362
Change	-	1.52%	-13.22%	10.86%	8.32%
Dividend per Share ¹	-	0.06	0.064	0.0718	0.08
Change	-	-	6.75%	12.02%	11.54%
Book Value Per Share ¹	1.768	1.793	1.862	1.984	2.104
Change	-	1.42%	3.85%	6.59%	6.03%
EPS ¹	0.115	0.113	0.158	0.1865	0.204
Change	-	-1.74%	39.85%	18.04%	9.34%
Nbr of stocks (in thousands)	9,234,574	9,234,574	9,120,871	9,120,871	9,120,871
Announcement Date	02/03/23	29/02/24	-	-	-